Literature DB >> 9723704

Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation.

U A Betz1, W Müller.   

Abstract

The functional receptor for the inflammatory cytokine IL-6 is composed of the ligand binding IL-6 receptor alpha chain (IL-6R alpha) and the signal transducing chain gp130, which is a shared component of multiple cytokine receptors. We analyzed the surface expression of gp130 and IL-6R alpha in thymocytes and peripheral T cells. While all thymocytes expressed gp130 throughout thymic maturation, they gained expression of IL-6R alpha at the CD4 or CD8 single-positive stage. Approximately 10-30% of the CD4-CD8+ and 40-50% of the CD4+CD8- thymocytes expressed IL-6R alpha. Within the CD4+CD8- population, the IL-6R alpha- subpopulation was cortisone sensitive, appeared immature according to the cell surface markers expressed and failed to proliferate after TCR cross-linking. Peripheral T cells were predominantly gp130+ and IL-6R alpha+, but down-regulated gp130 and IL-6R alpha expression upon TCR engagement in vitro and in vivo. Peripheral gp130low/-IL-6R alphalow/- T cells expressed surface markers characteristic of memory T cells. We show that gp130 and IL-6R alpha are expressed in a regulated manner in T cells, depending on the developmental and functional stage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723704     DOI: 10.1093/intimm/10.8.1175

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  35 in total

1.  The composition and signaling of the IL-35 receptor are unconventional.

Authors:  Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal:  Nat Immunol       Date:  2012-02-05       Impact factor: 25.606

2.  Differential T Cell Cytokine Receptivity and Not Signal Quality Distinguishes IL-6 and IL-10 Signaling during Th17 Differentiation.

Authors:  Lindsay L Jones; Rajshekhar Alli; Bofeng Li; Terrence L Geiger
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

3.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

4.  Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate.

Authors:  Rahul Sharma; Sun-Sang J Sung; Chiao-Ying A Ju; Umesh S Deshmukh; Shu Man Fu; Shyr-Te Ju
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

Review 5.  Omega-3 fatty acids, lipid rafts, and T cell signaling.

Authors:  Tim Y Hou; David N McMurray; Robert S Chapkin
Journal:  Eur J Pharmacol       Date:  2015-05-20       Impact factor: 4.432

Review 6.  Regulation generation: the suppressive functions of human regulatory T cells.

Authors:  Wendy A Goodman; Kevin D Cooper; Thomas S McCormick
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 7.  Paths to stemness: building the ultimate antitumour T cell.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

8.  Persistent loss of IL-27 responsiveness in CD8+ memory T cells abrogates IL-10 expression in a recall response.

Authors:  Georgia Perona-Wright; Jacob E Kohlmeier; Elizabeth Bassity; Tori C Freitas; Katja Mohrs; Tres Cookenham; Haozhong Situ; Edward J Pearce; David L Woodland; Markus Mohrs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

9.  Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response.

Authors:  Yuxiang Rui; Tasuku Honjo; Shunsuke Chikuma
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.

Authors:  Dongrui Wang; Brenda Aguilar; Renate Starr; Darya Alizadeh; Alfonso Brito; Aniee Sarkissian; Julie R Ostberg; Stephen J Forman; Christine E Brown
Journal:  JCI Insight       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.